Nordic Nanovector
Committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care.
Launch date
Employees
Market cap
AUD54.7m
Enterprise valuation
AUD40m (Public information from Jun 2023)
Share price
NOK1.018 NANOV.F
Oslo Norway (HQ)
Authorizing premium user...